round 800 people attended the PDA Universe of Prefilled Syringes Conference held in Basel on November 5th and 6th, which demonstrated just how active the injection device area of drug delivery currently is.
One of the key themes that I took away from the event was the need to address non-adherence in drug treatments regimens. This represents both a loss of commercial opportunity for pharma companies, but also a potential cost to healthcare providers through complications arising from poor disease control. From a patient perspective it has a number of negative implications ranging from increased risk of death to a lower quality of life. Read More >